(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BIOMATLANTE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

BIOMATLANTE

ST13

US500000079087322

Classe

5, 10, 40

Pedido

79087322

Registro

4078582

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

51

Atualização mais recente

22/05/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 40

Data de depósito

09/07/2010

Data de registro

03/01/2012

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

15/07/2022

Última transação

15/07/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

FR

Examinador

GAYNOR, BARBARA

Unidade examinadora

M60

Titulares e representantes

Titulares

BIOMATLANTE

Representantes

Joseph Sofer IPSILON USA

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 40

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Sanitary preparations for surgical use; material for stopping teethdental wax; dental amalgams; living surgical tissues; bone cements for surgical and orthopedic use; dental cements; phosphocalcic cements for reconstructive bone surgery; reabsorbable phosphocalcic cements for reconstructive bone surgery; surgical implants comprising living tissues; living tissue implant holders and anchoring devices for implants; biocompatible collagen foams and membranes for surgical covering and regeneration of cartilage defects; reabsorbable collagen dressings for medical and surgical use; matrices for tissue engineeringsurgical tissues

Classe 10

Surgical implants comprising artificial material; synthetic bone substitutes for surgical use for bone reconstruction; synthetic filler and extender material to serve as replacement for bonebiomaterials of calcium phosphate for reconstructive bone surgery; calcium phosphate granules for surgical use for bone reconstruction; medical and surgical apparatus and instruments for use in generalspinalorthopedicdental and maxillofacial surgery; reabsorbable medical osteosynthesis devicesbone substituteshydrated bone substitutesself-hardeningnon self-hardeningin situ hardening bone substitutesreabsorbable screws; systems for fixing soft tissuesurgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgeryrepairreinforcementbuttressing of soft-tissuereplacement parts and fittings therefor; orthopedic fixing screws; syringes for medical and surgical use; medical devices in the nature of spinal and osteoarticular arthrodesis systems comprised of bone substituteshydrated bone substitutesself-hardeningnon self-hardeningin situ hardening bone substitutes for use in generalspinalorthopedicdental and maxillofacial and reconstructive surgery; medical implants of artificial material in particular for anchoring the joints of fixed components and autografts

Classe 40

Mechanical treatment and coating of surgical implant surfaces by technological means; treatment of human bone for surgical implants

Publicações

Histórico de despachos e eventos da marca no USPTO.

51 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

22/05/2023

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

21/04/2023

INPC

INVALIDATION PROCESSED

21/04/2023

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

15/03/2023

C71T

CANCELLED SECTION 71

15/07/2022

RNWL

INTERNATIONAL REGISTRATION RENEWED

23/07/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/02/2019

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

26/10/2018

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

20/09/2018

INPC

INVALIDATION PROCESSED

20/09/2018

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

16/09/2018

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED

16/01/2018

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

16/01/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/01/2018

ES75

TEAS SECTION 71 & 15 RECEIVED

20/12/2017

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/01/2017

CORV

REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD

07/08/2015

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/08/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/05/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/08/2012

FIMP

FINAL DISPOSITION PROCESSED

08/08/2012

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/04/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

03/01/2012

GPNX

NOTIFICATION PROCESSED BY IB

23/12/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

18/10/2011

PUBO

PUBLISHED FOR OPPOSITION

18/10/2011

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

28/09/2011

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

28/09/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

14/09/2011

ALIE

ASSIGNED TO LIE

09/09/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

26/08/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

26/08/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

26/08/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

26/08/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

26/08/2011

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/04/2011

GNFR

FINAL REFUSAL E-MAILED

07/04/2011

CNFR

FINAL REFUSAL WRITTEN

07/04/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/04/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/04/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/04/2011

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

31/03/2011

RFNT

REFUSAL PROCESSED BY IB

13/11/2010

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

25/10/2010

RFRR

REFUSAL PROCESSED BY MPU

25/10/2010

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

23/10/2010

CNRT

NON-FINAL ACTION WRITTEN

22/10/2010

DOCK

ASSIGNED TO EXAMINER

22/10/2010

MAFR

APPLICATION FILING RECEIPT MAILED

19/10/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

15/10/2010

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

14/10/2010

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BIOMATLANTE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.